AORT Stock Analysis: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$34.26
0.10 (0.29%)
▲
5d:
-5.85%
30d:
-11.01%
90d:
-24.88%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 04, 2026
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AORT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: AORT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$56.28
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$34.94
2.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $34.26, which is considered oversold relative to its 30-day fair value range of $35.33 to $37.75. From a valuation perspective, the stock is trading at a discount (Forward PE: 29.6) compared to its historical average (44.1). Remarkably, the market is currently pricing in an annual earnings decline of 12.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is in a strong downtrend. Immediate support is located at $32.84, while resistance sits at $37.20.
Market Sentiment: AORT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $51.43 (+50.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AORT is in a strong downtrend. Immediate support is located at $32.84, while resistance sits at $37.20.
Market Sentiment: AORT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $51.43 (+50.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$35.33 -
$37.75
Company Quality Score
50/100
(HOLD)
Options IV Signal
47th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding AORT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 47th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 50.6% below Wall St target ($51.43)
- CAUTION: 5-day price weakness (-5.9%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$35.33 -
$37.75
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$3.73
(10.9%)
Support & Resistance Levels
Support Level
$32.84
Resistance Level
$37.20
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
29.55
Wall Street Target
$51.43
(+50.6%)
Revenue Growth (YoY)
19.2%
Profit Margin
2.2%
Valuation Discount vs History
-12.5% cheaper
PE vs Historical
29.6 vs 44.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-12.5%
(market-implied from PE analysis)
1-Year Target
$30.74
(-10%)
2-Year Target
$27.67
(-19%)
3-Year Target
$24.90
(-27%)
3-Yr Target (if PE normalizes)
(PE: 30→44)
$37.16
(+9%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.6, Growth: 42.4%)
$98.57
(+189%)
Base:
(SPY PE: 22.4, Growth: 42.4%)
$74.55
(+118%)
Bear:
(PE: 19.0, Growth: 42.4%)
$63.37
(+86%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (57x PE), but valuation improves significantly next year (30x PE) as earnings recover.
Forward PE: 57.47 | Forward EPS (Implied): $0.62
Bull Case
$43.13
(+21%)
Analyst growth 15.0%, PE expands to 60.3
Base Case
$35.72
(0%)
Market implied 0.0%, PE stable at 57.5
Bear Case
$27.33
(-24%)
Severe decline -15.0%, PE contracts to 51.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 29.6 to 44.1
Stabilization Target:
$50.98
(+49.2%)
PE Expansion Potential:
+49.2%
Share & Embed Analysis
Last updated: April 02, 2026 2:28 PM ET
Data refreshes hourly during market hours. Next update: 3:28 PM
Data refreshes hourly during market hours. Next update: 3:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Jean F Holloway
SELL
8962 shares
2026-03-04
Marshall S Stanton
SELL
2149 shares
2026-03-03
Lance A Berry
SELL
6316 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
